These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 34684760)

  • 21. MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future.
    Simon V; Cota D
    Eur J Endocrinol; 2017 Jun; 176(6):R309-R324. PubMed ID: 28246151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis.
    Cota D; Marsicano G; Tschöp M; Grübler Y; Flachskamm C; Schubert M; Auer D; Yassouridis A; Thöne-Reineke C; Ortmann S; Tomassoni F; Cervino C; Nisoli E; Linthorst AC; Pasquali R; Lutz B; Stalla GK; Pagotto U
    J Clin Invest; 2003 Aug; 112(3):423-31. PubMed ID: 12897210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reports of the death of CB1 antagonists have been greatly exaggerated: recent preclinical findings predict improved safety in the treatment of obesity.
    McLaughlin PJ
    Behav Pharmacol; 2012 Sep; 23(5-6):537-50. PubMed ID: 22743603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthetic Cannabinoid Receptor Agonists and Antagonists: Implication in CNS Disorders.
    Manera C; Arena C; Chicca A
    Recent Pat CNS Drug Discov; 2016; 10(2):142-156. PubMed ID: 27193072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocannabinoid System: A Multi-Facet Therapeutic Target.
    Kaur R; Ambwani SR; Singh S
    Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocannabinoids and the gastrointestinal tract: what are the key questions?
    Sanger GJ
    Br J Pharmacol; 2007 Nov; 152(5):663-70. PubMed ID: 17767170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
    Mulè F; Amato A; Baldassano S; Serio R
    Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological actions of cannabinoids.
    Pertwee RG
    Handb Exp Pharmacol; 2005; (168):1-51. PubMed ID: 16596770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood.
    Fride E; Bregman T; Kirkham TC
    Exp Biol Med (Maywood); 2005 Apr; 230(4):225-34. PubMed ID: 15792943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoid Receptors in Metabolic Regulation and Diabetes.
    Rohbeck E; Eckel J; Romacho T
    Physiology (Bethesda); 2021 Mar; 36(2):102-113. PubMed ID: 33595385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis.
    Janero DR; Makriyannis A
    Expert Opin Emerg Drugs; 2009 Mar; 14(1):43-65. PubMed ID: 19249987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adipocyte cannabinoid receptor CB1: a relevant target for obesity!].
    Gilgenkrantz H; Lotersztajn S
    Med Sci (Paris); 2018 Apr; 34(4):296-299. PubMed ID: 29658468
    [No Abstract]   [Full Text] [Related]  

  • 33. Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia.
    Lichtman AH; Shelton CC; Advani T; Cravatt BF
    Pain; 2004 Jun; 109(3):319-327. PubMed ID: 15157693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Endocannabinoid System and Alcohol Dependence: Will Cannabinoid Receptor 2 Agonism be More Fruitful than Cannabinoid Receptor 1 Antagonism?
    Oppong-Damoah A; Gannon BM; Murnane KS
    CNS Neurol Disord Drug Targets; 2022; 21(1):3-13. PubMed ID: 33573565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacology of cannabinoid receptors and their ligands: an overview.
    Pertwee RG
    Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocannabinoid modulation of scratching response in an acute allergenic model: a new prospective neural therapeutic target for pruritus.
    Schlosburg JE; Boger DL; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2009 Apr; 329(1):314-23. PubMed ID: 19168707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The endocannabinoid-CB receptor system: Importance for development and in pediatric disease.
    Fride E
    Neuro Endocrinol Lett; 2004; 25(1-2):24-30. PubMed ID: 15159678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modern approaches to the development of synthetic cannabinoid receptor probes.
    Saldaña-Shumaker SL; Grenning AJ; Cunningham CW
    Pharmacol Biochem Behav; 2021 Apr; 203():173119. PubMed ID: 33508249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The emerging role of the endocannabinoid system in endocrine regulation and energy balance.
    Pagotto U; Marsicano G; Cota D; Lutz B; Pasquali R
    Endocr Rev; 2006 Feb; 27(1):73-100. PubMed ID: 16306385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
    Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.